Myint Han 4
4 · NextCure, Inc. · Filed Jan 19, 2021
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Myint Han
Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-01-13+200,000→ 200,000 totalExercise: $12.09Exp: 2031-01-12→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 11, 2022. The remainder vests in 36 monthly installments beginning on February 11, 2022.